Sangeet, Ghai,,
Ni, Tiffany T.,
Pavlovich, Christian P.,
Futterer, Jurgen J.,
Schade, George R.,
Sanchez-Salas, Rafael,
Cornud, Francois,
Eggener, Scott,
Feller, John F.,
George, Arvin K.,
Villers, Arnauld,
de la Rosette, Jean (2025) , demonstrating positive outcomes in oncologic
control and preservation of urinary and sexual function. TULSA
Nurgalieva, A.Kh.,
Mustafin, S.A.,
Petrova, S.G.,
Ekomasova, N.V.,
Sakaeva, D.D.,
Fedorova, Y.Y.,
Abdeeva, G.R.,
Dzhaubermezov, M.A.,
Abdeev, R.R.,
Rakhimov, R.R.,
Khusnutdinova, E.K.,
Prokofyeva, D.S. (2024) with cancer and
controls when combining samples of Tatars and Bashkirs. We hypothesize that polymorphism rs
of this genome
control mechanism is aimed at achieving a mature state, after which unprogrammed activation
Evdakov, V.A.,
Starodubov, V.I.,
Oleynik, B.A.,
Sharafutdinova, N.Kh.,
Borisova, M.V.,
Plechev, V.V. (2023) in recent decades, and that is largely associated with
control of risk factors and improvement of acute
Фенотипические проявления дисплазии соединительной ткани у лиц с гипермобильностью суставовAkhiiarova, Karina E.,
Gantseva, Khalida Kh,
Khusainova, Rita I.,
Tyurin, Anton V.,
Ахиярова, К.Э.,
Ганцева, Х.Х.,
Хусаинова, Р.И.,
Тюрин, А.В. (2022) – with the presence of HMS (n = 156) and the
control group (n = 105). JH was determined according to the Beighton